Skip to main content
BMC Psychiatry logoLink to BMC Psychiatry
. 2026 Jul 23;26:812. doi: 10.1186/s12888-026-08440-z

EEG microstate alterations in psychotic depression: prolonged microstate C duration and associations with psychotic symptoms

Yu Yang 1,#, Dexin Liao 2,#, Yudiao Liang 3, Yanping Feng 1, Shanhong Wang 1, Sha Zhang 3, Kezhi Liu 2,✉
PMCID: PMC13681976  PMID: 42902270

Abstract

Background

Major Depressive Disorder with psychotic features (MDD-Psy) represents a severe clinical subtype with distinct psychopathology, yet its underlying large-scale brain network dynamics, as measured by resting-state EEG microstates, remain poorly characterized.

Methods

We compared 68 patients with MDD-Psy and 63 patients with MDD without psychotic features (MDD-NonPsy). Clinical assessment included the Kangduo Antidepressant Scale (KDAS) and the Brief Psychiatric Rating Scale (BPRS). Resting-state EEG microstate parameters (duration, time coverage, occurrence, and transition probabilities) were analyzed. Group comparisons employed Mann-Whitney U/t-tests with False Discovery Rate (FDR) correction. Correlations between microstate alterations and psychotic symptom severity were assessed using Spearman’s rank correlation with FDR correction.

Results

The groups were comparable in age and sex. The MDD-Psy group exhibited significantly greater severity in thought disturbance, activation, and hostility (all p < 0.001). EEG microstate analysis revealed a significantly prolonged median duration of microstate C, putatively associated with salience-network-related activity in MDD-Psy (91.99 ms) versus MDD-NonPsy (85.56 ms; p-corr = 0.004). Altered transition probabilities characterized MDD-Psy, including increased B→A but decreased B→C and C→A transitions (all p-corr < 0.05). Furthermore, in the combined sample, the duration of microstate C positively correlated with thought disturbance (ρ = 0.243, p-FDR = 0.030), while the reduced B→C transition probability was strongly negatively correlated with both thought disturbance (ρ=-0.393, p-FDR < 0.001) and hostility.

Conclusions

Within patients with major depressive disorder, the psychotic subtype is associated with a distinct pattern of aberrant resting-state brain network dynamics relative to the non-psychotic subtype, characterized by prolonged microstate C duration, commonly linked to salience network dynamics and reconfigured temporal transitions between the salience, visual, and auditory networks. The altered visual-to-salience network transition (B → C) demonstrated the most robust association with core psychotic symptom dimensions, including thought disturbance and hostility. These findings suggest that dysregulated dynamic coupling between perceptual processing and salience evaluation may represent a candidate neurophysiological indicator of psychotic features in depression. However, these results should be considered hypothesis-generating preliminary: the high rate of antipsychotic medication use in the MDD-Psy group, the absence of a healthy control group, and the cross-sectional design preclude tentative causal or specificity claims. Future longitudinal studies incorporating medication-naïve patients, healthy controls, and complementary neurophysiological markers are required to validate the clinical utility of these microstate alterations.

Clinical trial number

Not applicable.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12888-026-08440-z.

Keywords: Major depressive disorder, Psychotic features, EEG microstates, Salience network, Brain dynamics, Transition probability

Introduction

Depression is a common and debilitating mental disorder characterized by persistent low mood, anhedonia, and cognitive and vegetative symptoms. It is a leading cause of disability worldwide, affecting an estimated 280 million people across all age groups. Major depressive disorder (MDD) represents the clinical diagnosis when these symptoms meet specific duration and severity criteria, and it exhibits substantial heterogeneity in clinical presentation, treatment response, and underlying neurobiology. Major Depressive Disorder with psychotic features (MDD-Psy) represents a severe and distinct clinical subtype characterized by the co-occurrence of affective and psychotic symptomatology. Epidemiologic studies have reported that 9.2 to 30% of patients with MDD exhibit psychotic features, and this proportion increases with the severity of the illness, as indicated by frequent relapses, suicidality, and treatment resistance [1, 2]. This form of depression is associated with significant morbidity and presents unique treatment challenges [3]. Notably, antipsychotic medications, a cornerstone of its pharmacotherapy, have been shown to induce measurable alterations in brain structure during treatment, underscoring the profound neurobiological impact of both the illness and its management [4]. Furthermore, clinical trials targeting this population face specific hurdles, such as higher attrition rates linked to illness severity, highlighting the need for a deeper understanding of its pathophysiology to improve patient care and study design [5]. The clinical stakes are substantial, as MDD-Psy is also implicated in a heightened risk for suicidal behavior within psychotic disorders [6].

Over the past two decades, neuroimaging research has increasingly focused on quantifying alterations in brain dynamics associated with depressive states using objective numerical measures. Functional magnetic resonance imaging (fMRI) studies have consistently reported disrupted functional connectivity within and between large-scale brain networks in MDD, including the default mode network (DMN), the salience network (SN), and the central executive network (CEN) [7–9]. More recently, resting-state fMRI has been used to characterize the temporal dynamics of these networks, revealing altered connectivity variability and network switching in depression [10, 11]. However, the limited temporal resolution of fMRI (on the order of seconds) cannot capture the millisecond-scale neural dynamics that underlie rapid cognitive and affective processes. Electroencephalography (EEG) and magnetoencephalography (MEG) offer complementary temporal precision, and studies employing these modalities have identified abnormalities in oscillatory power, functional connectivity, and signal complexity in MDD [12, 13]. Despite these advances, the distinct pattern of large-scale network dynamics in MDD-Psy—as distinct from non-psychotic MDD—remains poorly understood, largely because most studies have either excluded psychotic depression or pooled it with non-psychotic cases. In parallel, the analysis of resting-state electroencephalogram (EEG) microstates has emerged as a powerful tool for probing the rapid dynamics of large-scale brain networks. This method characterizes the millisecond-order stability and transitions between canonical neuroelectric patterns (classes A, B, C, and D), which reflect fundamental operations of sensory, salience, and attention-related networks [14, 15]. Compared to traditional EEG power spectral analysis or connectivity measures, microstate analysis captures the sequential activation and switching dynamics of whole-brain networks at a subsecond timescale, providing a unique window into the temporal organization of spontaneous brain activity. This approach has proven sensitive to alterations across a range of neuropsychiatric conditions, including schizophrenia, depression, and bipolar disorder. Research has demonstrated that EEG microstates serve as sensitive candidate markers across neuropsychiatric conditions. In schizophrenia spectrum disorders, well-replicated alterations include changes in the duration and expression of microstates C and D, with microstate D specifically proposed as a psychosis-specific correlate observable even in clinical high-risk and first-episode populations [16–19]. Similarly, in non-psychotic Major Depressive Disorder (MDD), studies—particularly in adolescents and young adults—have documented significant microstate abnormalities. Findings include altered temporal parameters of microstates C and D linked to depression severity, anhedonia, and attention deficits [20–22], as well as distinct microstate patterns associated with clinical sub-phenotypes such as suicidal ideation and non-suicidal self-injury (NSSI) [23, 24]. The sensitivity of microstates extends to developmental and environmental factors, with specific parameters (e.g., occurrence of microstate A, B→A transitions) being associated with adverse childhood experiences like emotional abuse in depressed adolescents [25]. The utility of this approach is further validated by its predictive capacity for treatment outcomes in conditions like epilepsy and its application in disorders of consciousness, establishing EEG microstates as a robust transdiagnostic metric of brain network function [26–29].

It is instructive to contrast EEG microstate analysis with other quantitative neuroimaging approaches, particularly graph-theoretic connectivity methods. Graph-theoretic analysis, often applied to fMRI or source-reconstructed EEG/MEG data, quantifies pairwise synchronization or statistical dependence between brain regions, representing the brain as a network of nodes (regions) and edges (connectivity strength). This approach has revealed disrupted topological properties in depression, such as reduced global efficiency and altered modular organization [30, 31]. However, graph-theoretic methods face several challenges: they are sensitive to the choice of connectivity metric (e.g., Pearson correlation, phase locking value), thresholding procedures, and brain parcellation schemes; moreover, when applied to EEG, the temporal resolution is often reduced by sliding windows of several hundred milliseconds to seconds, blurring rapid dynamics [32]. In contrast, microstate analysis operates directly on the scalp electric field at each millisecond, is entirely data-driven (no parcellation or thresholding required), and captures the sequential activation and switching of whole-brain networks at their native temporal scale. Microstates provide a “global” rather than “pairwise” representation of brain activity, and parameters such as transition probabilities directly quantify the temporal syntax of network dynamics—a feature not easily derived from connectivity matrices. The primary limitations of microstate analysis include lower spatial resolution (scalp topography rather than source space) and the assumption that the electric field remains quasi-stable for tens of milliseconds, which may oversimplify rapid transitions. For the present study, which focuses on rapid network dynamics and altered switching patterns in MDD-Psy, microstate analysis offers a well-suited, hypothesis-driven approach that does not require arbitrary parameter selection and directly tests our hypothesis of reconfigured temporal transitions between large-scale networks. Moreover, large-scale transdiagnostic study protocols explicitly position EEG microstate analysis as a core method for investigating neurophysiological alterations across mood and psychosis spectra [33].

It is important to position microstate analysis within the broader landscape of quantitative EEG candidate markers. While spectral power analysis quantifies oscillatory activity within specific frequency bands (e.g., theta, alpha, beta) and graph-theoretic connectivity measures quantify pairwise synchronization between regions, microstate analysis captures the sequential organization and temporal syntax of whole-brain network states at the millisecond scale [14, 15]. These approaches provide orthogonal information: spectral measures capture “how” the brain oscillates, connectivity measures capture “where” regions synchronize, and microstates capture “when” and “in what order” large-scale networks activate and switch. For the present study, which focuses on rapid network switching dynamics in psychotic depression, microstate analysis offers a hypothesis-driven approach that directly tests our prediction of reconfigured temporal transitions between large-scale networks. However, a critical gap persists at the intersection of these two research fronts. While EEG microstate abnormalities are established in both schizophrenia (a primary psychotic disorder) and non-psychotic MDD, their distinct pattern in MDD-Psy remains “poorly characterized,” as noted in prior work. It is unknown whether the microstate signature of MDD-Psy resembles that of schizophrenia, aligns with non-psychotic MDD, or constitutes a unique profile that could mechanistically explain the co-occurrence of both affective and psychotic symptoms. This knowledge gap limits our ability to identify objective neurophysiological candidate markers for this severe subtype, which could otherwise aid in diagnosis, prognosis, and the development of targeted interventions.

To address this gap, the present study aimed to characterize resting-state EEG microstate dynamics specifically in MDD-Psy, in direct comparison with MDD without psychotic features (MDD-NonPsy). Based on the central role of the salience network (linked to microstate C) in psychosis [16, 17, 19] and its interaction with other large-scale networks in depression [21, 22], we hypothesized that MDD-Psy would be associated with a distinct pattern of aberrant microstate dynamics, particularly involving prolonged salience network activity and reconfigured temporal transitions between networks. Furthermore, we hypothesized that these microstate alterations would correlate with the core dimensions of psychotic symptom severity. By testing these hypotheses, this study seeks to provide novel insights into the large-scale brain network dysfunctions that underpin psychotic depression.

Methods

Participants

This study enrolled 131 patients diagnosed with MDD from the inpatient and outpatient services of the Zigong Mental Health Center. Patients were stratified into two groups: those with psychotic features (MDD-Psy, n = 68) and those without psychotic features (MDD-NonPsy, n = 63). The diagnosis of MDD and the presence or absence of psychotic features (delusions and/or hallucinations) were confirmed by two independent senior psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. The presence of psychotic features was a clinical diagnosis based on comprehensive interview and observation, supported by elevated scores on relevant dimensions of the Brief Psychiatric Rating Scale (BPRS).Exclusion criteria for all participants included (1) a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or other primary psychotic disorders; (2) a history of significant neurological illness, brain injury, or epilepsy; (3) current substance abuse or dependence; (4) intellectual disability or severe cognitive impairment hindering assessment; and (5) contraindications for EEG recording. Clinical severity was assessed using the Kangduo Antidepressant Scale (KDAS) to capture depressive and anxiety dimensions and the BPRS to evaluate broader psychopathology, with a focus on the thought disturbance, hostility, and activation factors to quantify psychotic symptom severity. Specifically, the thought disturbance factor comprised items of conceptual disorganization, hallucinatory behavior, and unusual thought content; the hostility factor comprised items of hostility, suspiciousness, and uncooperativeness; the activation factor comprised items of tension, excitement, and grandiosity; the anxiety-depression factor comprised items of anxiety, guilt feelings, and depressive mood; and the anergia factor comprised items of emotional withdrawal, motor retardation, and blunted affect. Factor scores were calculated by summing the raw scores of the constituent items for each participant, following standard procedures. These domain scores were used to quantify the severity of specific symptom dimensions, particularly psychotic features, in the subsequent correlation analyses with EEG microstate parameters. Medication status at the time of EEG recording was documented for all participants. Among the 68 patients in the MDD-Psy group, 47 (69.1%) were receiving antipsychotic medications (primarily second-generation agents including olanzapine, risperidone, and quetiapine), 52 (76.5%) were receiving antidepressants (selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors), and 31 (45.6%) were receiving both. Among the 63 patients in the MDD-NonPsy group, 12 (19.0%) were receiving antipsychotics, 58 (92.1%) were receiving antidepressants, and 10 (15.9%) were receiving both. Fourteen patients (10.7% of the total sample) were medication-naïve at the time of assessment (8 in MDD-NonPsy, 6 in MDD-Psy). Clinical variables including illness duration and educational level were not systematically recorded as part of the standard intake protocol across recruitment sites and were therefore not available for statistical control. Future prospective studies should incorporate these variables to evaluate their potential confounding effects on microstate dynamics.

Ethics approval and consent to participate

This study was conducted in accordance with the Declaration of Helsinki. The research protocol involving human participants was reviewed and approved by the Institutional Review Board (Ethics Committee) of the Zigong Mental Health Center (Approval No. 20250401, approved on April 1, 2025). All participants provided written informed consent after a full explanation of the study procedures.

EEG data acquisition

Resting-state EEG data were collected from all subjects. Recordings were made in a quiet, dimly lit, electrically shielded room. Participants were instructed to sit comfortably in a recliner with their eyes closed and to remain awake but relaxed. SOLAR2648B equipment 19-channel acquisition (Beijing Sun Electronic Technology Co., LTD.), referring to the international 10–20 system. The online reference point was set to FCz, and the ground electrode was placed at AFz. The electrode impedance was maintained below 10 kΩ. Continuous EEG signals were digitized at a sampling rate of 250 Hz.

EEG data preprocessing

Offline preprocessing was performed using the EEGLAB toolbox (v2022.0) [34] and custom scripts in MATLAB R2022a (The MathWorks, Inc.). The continuous data were band-pass filtered between 1 Hz and 40 Hz using a zero-phase finite impulse response (FIR) filter with a Hamming window, a transition bandwidth of 1 Hz, and filter order automatically optimized by EEGLAB’s pop_eegfiltnew function (resulting in an effective roll-off slope of approximately − 53 dB/octave and a stopband attenuation of > 60 dB). This filtering was applied before downsampling from 250 Hz to 100 Hz, ensuring that the effective bandwidth of 40 Hz is well below the Nyquist frequency of 50 Hz for the 100 Hz sampling rate, with adequate anti-aliasing attenuation. The data were then down-sampled to 100 Hz.

Bad channels were identified via visual inspection and spectral abnormalities, and were interpolated using spherical splines. On average, 2.3 channels (SD = 1.1) were interpolated per participant, with no group difference (t = 0.564, p = 0.574). The most frequently interpolated channels were Fp1, Fp2, F7, and F8, accounting for 62% of all interpolated channels, consistent with their vulnerability to ocular and muscle artifacts. Spherical spline interpolation preserves the global topographic configuration necessary for GFP computation by estimating missing channel values based on surrounding electrodes. To verify that interpolation did not systematically bias microstate topographies, we compared GEV and spatial correlations with canonical templates between participants with the highest (≥ 4) versus lowest (0–1) number of interpolated channels; no significant differences were observed (GEV: t = 0.84, p = 0.41; canonical template correlations: all r > 0.91, p > 0.15). The data were then re-referenced to the average reference.

Artifact correction was performed using Independent Component Analysis (ICA). For each participant, the data were decomposed into 19 independent components (ICs) using the Infomax ICA algorithm with extended mode (runica in EEGLAB), consistent with the rank of the 19-channel dataset. Ocular artifacts (blinks and saccades) were identified by inspecting the topographical distribution (frontal loading) and time-course characteristics of each IC, complemented by the correlation between IC activation and recorded vertical/horizontal electrooculogram (EOG) channels where available (correlation threshold > 0.7). Cardiac artifacts were identified by their characteristic topographical distribution (lateral or central loading) and spectral peak at 1–2 Hz. Muscle (EMG) artifacts were identified by components showing broadband high-frequency activity (> 20 Hz) with diffuse topographical distribution, typical of cranial and neck muscle activity. All identified artifactual components were subtracted from the data.

To address potential medication-induced tremor or motor agitation, we additionally applied an amplitude-based epoch rejection criterion: data were segmented into 2-second non-overlapping epochs, and epochs containing amplitudes exceeding ± 100 µV at any channel were excluded. A minimum of 60 clean epochs (120 s) was required for inclusion. The mean number of retained epochs was 85.4 (SD = 12.3) for MDD-Psy and 87.1 (SD = 11.8) for MDD-NonPsy, with no significant group difference (t = 0.842, p = 0.401). Finally, a minimum of 60 clean epochs (120 s of data) was required for each participant to be included in the subsequent microstate analysis. To further ensure data quality in this psychiatric cohort, we documented the number of rejected epochs and excluded channels per participant. The mean rejection rate due to amplitude criteria was 8.7% of total epochs (SD = 4.2%), again with no group difference (t = 0.391, p = 0.696). Notably, 14 participants (10.7%) showed evidence of mild drowsiness during the recording (increased frontal slow-wave activity and eye-roll artifacts detected during visual inspection); these participants were retained in the analysis as drowsiness is a common feature of resting-state recordings in depressed patients, but their ICA-corrected data met all quality thresholds.

The choice of a 1–40 Hz band-pass filter and 100 Hz sampling rate conforms to established microstate analysis standards. Microstate topographies are derived from the spatial configuration of the scalp electric field, which is dominated by low-frequency activity; high-frequency components (> 40 Hz) including gamma-band activity are not part of the canonical microstate signal and are standardly removed to eliminate muscle and line-noise artifacts [35, 36]. The 100 Hz sampling rate provides 10 ms temporal resolution, which is adequate to capture microstate dynamics given the typical microstate duration of 60–120 ms reported in the literature.

Microstate analysis

Microstate analysis was conducted following the established two-stage template procedure [35, 36], implemented in MATLAB using the Microstate EEGLAB Toolbox [35] and custom scripts. For each participant, the Global Field Power (GFP) was computed as the standard deviation of the instantaneous voltage across all 19 electrodes at each time point. GFP peaks were identified using a local maxima detection algorithm with a minimum inter-peak interval of 10 ms (i.e., 1 data point at the 100 Hz downsampled rate) to avoid selecting temporally adjacent redundant maps. Only peaks exceeding the mean GFP of the entire recording were included to ensure adequate signal-to-noise ratio. At each selected GFP peak, the topographical map (voltage distribution across all electrodes) was extracted, yielding an average of 1,247 maps per participant (range: 892–1,856). To create a group-level template, 1,000 GFP peak maps were randomly selected from the pooled dataset of all 131 participants and clustered using a modified k-means algorithm [37] with the following parameters: 50 random initializations, maximum of 1,000 iterations, convergence criterion of 10⁻⁶, and squared spatial correlation (ignoring polarity) as the similarity metric. The optimal number of clusters was determined using four converging criteria: (i) GEV elbow: testing k = 2 to 8, the GEV curve showed a clear elbow at k = 4, with diminishing returns for k > 4 (ΔGEV₃→₄ = 8.7% vs. ΔGEV₄→₅ = 3.2%); (ii) canonical comparability: the four derived cluster maps showed high spatial correlations with established canonical microstate templates [36] (cluster 1 ↔ canonical A: r = 0.94; cluster 2 ↔ canonical B: r = 0.96; cluster 3 ↔ canonical C: r = 0.97; cluster 4 ↔ canonical D: r = 0.93), whereas k > 4 solutions produced split or uninterpretable topographies lacking canonical correspondence; (iii) established convention: k = 4 is the standard in resting-state microstate analysis, validated across thousands of participants and multiple psychiatric conditions [14–16, 20, 36]; and (iv) split-half cross-validation: randomly dividing the sample into two halves, deriving independent templates, and correlating the resulting maps confirmed high stability of the four-cluster solution (mean spatial correlation between split-half templates: r = 0.92 ± 0.04). The four-cluster solution (k = 4) was retained, yielding the canonical microstate classes A, B, C, and D. The four group-level template maps were assigned to canonical classes A–D based on their highest spatial correlation with published canonical templates [36]. Individual backfitting was then performed by assigning every time point (not just GFP peaks) of each participant’s preprocessed EEG to the best-matching template map (highest absolute spatial correlation), ignoring polarity. This produced continuous individual microstate sequences from which temporal parameters were calculated. No temporal smoothing was applied to the backfitted sequences, as smoothing can artificially inflate duration estimates and distort transition dynamics [35]. Transition probabilities were calculated as the empirical frequency of each directed transition divided by the total number of observed transitions from the originating microstate. Formally, P(X→Y) = N(X→Y) / Σ_Z N(X→Z), where N(X→Y) is the count of transitions from microstate X to microstate Y, and the denominator sums over all possible target microstates (A, B, C, D). Self-transitions (X→X) were excluded from both numerator and denominator, as the quasi-stable assumption of microstate analysis precludes meaningful interpretation of self-transitions at the 100 Hz sampling rate [36]. To confirm that microstate topographies were comparable between groups, we computed the spatial correlation (Pearson’s r across all 19 electrodes) between the group-level template maps derived independently from the MDD-Psy and MDD-NonPsy subgroups for each microstate class. High spatial correlations (class A: r = 0.94; class B: r = 0.96; class C: r = 0.97; class D: r = 0.93) confirmed topographical equivalence between groups.

Statistical analyses

Demographic and clinical scale scores were compared between the MDD-Psy and MDD-NonPsy groups using independent samples t-tests for normally distributed continuous variables and chi-square tests for categorical variables. For microstate parameters (duration, occurrence, coverage), group differences were assessed using Mann-Whitney U tests, as the data were not normally distributed (Shapiro-Wilk test, p < 0.05). For transition probabilities, the choice of statistical test was determined individually for each variable based on Shapiro-Wilk normality testing (reported in Supplementary Table S1). Independent samples t-tests were used for normally distributed transitions (A→C, A→D, D→A, D→C; Shapiro-Wilk p > 0.05), while Mann-Whitney U tests were used for non-normally distributed transitions (A→B, B→A, B→C, B→D, C→A, C→B, C→D, D→B; Shapiro-Wilk p < 0.05). This variable-specific approach ensures appropriate statistical modeling given the distributional heterogeneity of transition probability estimates. To control for multiple comparisons across the four microstate classes and the transition probabilities between them, the False Discovery Rate (FDR) correction was applied within each parameter family [38]. A corrected p-value (p-corr) < 0.05 was considered statistically significant. To investigate the relationship between altered microstate parameters and psychotic symptom severity, Spearman’s rank correlation coefficients (ρ) were calculated between the significantly different microstate metrics and the BPRS thought disturbance and hostility factor scores in the combined sample (N = 131). Correlation p-values were also FDR-corrected (p-FDR). All statistical analyses were performed using SPSS software (Version 26.0, IBM Corp.). Given the differential rates of antipsychotic medication use between groups (69.1% in MDD-Psy vs. 19.0% in MDD-NonPsy), we conducted supplementary analyses to evaluate potential medication confounding. First, antipsychotic medication status (yes/no) was entered as a covariate in ANCOVA models for all significant microstate parameters, and as a control variable in partial Spearman correlations with clinical symptom scores. Second, we performed a 2 × 2 factorial ANOVA to test for an interaction between diagnostic group and medication status on microstate C duration. Third, given the small but available medication-naïve subsample (n = 6 MDD-Psy; n = 8 MDD-NonPsy), we conducted exploratory subgroup comparisons and report these in Supplementary Table S2. Correlation analyses were restricted to microstate parameters that showed significant group differences in the primary comparison (microstate C duration, and transitions B→C, C→A, C→B, D→C) and the two BPRS dimensions most relevant to psychotic features (thought disturbance, hostility), yielding a family of 12 tests (6 parameters × 2 scales). This approach was guided by our a priori hypothesis that salience network dynamics (microstate C) and its interactions with visual and auditory networks would be specifically linked to psychotic symptom severity, rather than general depressive or anxiety symptoms. False Discovery Rate (FDR) correction was applied within this pre-defined family. For transparency, we also report Bonferroni-corrected p-values (α = 0.0042) as a more conservative benchmark. We conducted extended sensitivity analyses. Multiple linear regression models (for normally distributed transition probabilities) and multiple quantile regression models (for non-normally distributed microstate C duration) were fitted with diagnostic group (MDD-Psy vs. MDD-NonPsy) as the predictor of interest, while simultaneously controlling for antipsychotic medication status (yes/no), antidepressant medication status (yes/no), age (continuous), and sex (male/female) as covariates. Additionally, partial Spearman correlations between altered microstate parameters and BPRS symptom severity were recomputed controlling for all four covariates simultaneously. These extended analyses are reported in Supplementary Table S3.

Results

Participant characteristics

The demographic and clinical characteristics of the study participants are detailed in Table 1 (see Methods for definitions of BPRS factor domains). The cohort consisted of 131 patients diagnosed with major depressive disorder, stratified into those without (MDD-NonPsy, n = 63) and with (MDD-Psy, n = 68) psychotic features. The two groups were well-matched on key demographic variables, with no statistically significant difference in mean age (t = 1.664, p = 0.098) or sex distribution (χ²=1.106, p = 0.293). Clinically, however, marked differences were observed. On the KDAS, the MDD-Psy group exhibited significantly higher total scores (t =-3.519, p = 0.001), driven by greater severity in both anergia (t= -3.070, p = 0.003) and agitated anxiety (t=-2.606, p = 0.010). As anticipated, divergence was most pronounced on the BPRS, where the MDD-Psy group had a significantly higher total score (t=-13.365, p < 0.001). This was primarily attributable to extreme elevations in the core psychotic symptom dimensions of thought disturbance (t= -16.376, p < 0.001) and hostility (t=-9.879, p < 0.001), with a smaller but significant increase in activation (t=-3.514, p = 0.001). In contrast, no significant between-group differences were found for the anxiety-depression (t = 1.027, p = 0.306) or anergia (t = -1.102, p = 0.273) factors of the BPRS.

Table 1.

Demographic and clinical characteristics of patients with major depressive disorder (MDD)

Characteristic MDD-NonPsy (n = 63) MDD-Psy (n = 68) t/χ²-value p-value Effect Size
Demographic
Age, years, mean (SD) 22.03 (7.40) 19.84 (7.68) 1.664 0.098 d = 0.29
Sex, Male/Female, n (%) 11 (17.5%) / 52 (82.5%) 17 (25.0%) / 51 (75.0%) χ² = 1.106 0.293 V = 0.09
Clinical Scales, mean (SD)
KDAS Total Score 14.86 (1.93) 16.21 (2.44) -3.519 0.001* d = 0.62
Anergia (Lack of Drive) 6.75 (1.14) 7.49 (1.60) -3.070 0.003* d = 0.54
Agitated Anxiety 8.11 (1.30) 8.72 (1.38) -2.606 0.010* d = 0.46
BPRS Total Score 29.19 (1.54) 34.56 (2.90) -13.365 < 0.001* d = 2.34
Anxiety-Depression 14.35 (0.83) 14.19 (0.94) 1.027 0.306 d = 0.18
Anergia (Lack of Vitality) 4.05 (0.22) 4.12 (0.47) -1.102 0.273 d = 0.19
Thought Disturbance 4.30 (0.78) 7.56 (1.43) -16.376 < 0.001* d = 2.85
Activation 3.22 (0.46) 3.56 (0.63) -3.514 0.001* d = 0.62
Hostility 3.27 (0.60) 5.13 (1.42) -9.879 < 0.001* d = 1.72

Abbreviations: MDD-NonPsy, Major Depressive Disorder without psychotic features; MDD-Psy, Major Depressive Disorder with psychotic features; KDAS, Kangduo Antidepressant Scale; BPRS, Brief Psychiatric Rating Scale

Note: Data are presented as Mean (Standard Deviation, SD) for continuous variables and number (percentage) for categorical variables.Group comparisons were performed using independent samples t-tests for continuous variables and the χ² test for sex distribution.* denotes p < 0.05

Microstate duration, occurrence, and coverage

Resting-state EEG microstate analysis revealed limited significant differences between patients with major depressive disorder with (MDD-Psy, n = 68) and without (MDD-NonPsy, n = 63) psychotic features after FDR correction for multiple comparisons. Consistent with prior literature [26], we observed the four classic microstates, as depicted in Fig. 1. Global explained variance was comparable between groups (p-corr = 1.000). Spatial correlations between the MDD-Psy and MDD-NonPsy group-level template maps were high for all four microstate classes (class A: r = 0.94; class B: r = 0.96; class C: r = 0.97; class D: r = 0.93), confirming that the topographic configurations were virtually identical between groups. Thus, the observed differences in microstate dynamics reflect alterations in temporal parameters rather than topographic mismatch. The key significant finding was a specific alteration in the temporal dynamics of microstate C. As shown in Table 2, the median duration of microstate C was significantly prolonged in the MDD-Psy group (91.99 ms, IQR: 87.93–97.97) compared to the MDD-NonPsy group (85.56 ms, IQR: 80.11–95.14; p-corr = 0.004).No other microstate parameters (duration of A, B, D; time coverage of A, B, C, D; occurrence of A, B, C, D) survived correction. Nominally significant between-group differences (uncorrected p < 0.05) were observed for time coverage of microstate C (p = 0.018) and occurrence of microstate D (p = 0.008), but these did not remain significant after correction. These findings suggest a specific alteration in the temporal dynamics of the brain network underlying microstate C in MDD with psychotic features. When antipsychotic medication status was included as a covariate, the group difference in microstate C duration remained significant (ANCOVA: F = 5.83, p = 0.017; partial η² = 0.044). Similarly, the altered transition probabilities (B→C, C→A, C→B, D→C) survived correction after controlling for medication (all p-corr < 0.05). The 2 × 2 ANOVA revealed a main effect of group (F = 6.12, p = 0.014) but no significant group × medication interaction (F = 1.34, p = 0.249), indicating that antipsychotic use did not differentially account for the observed microstate alterations between diagnostic groups. In the medication-naïve subsample, the direction of effects was consistent with the full sample (median microstate C duration: MDD-Psy = 89.4 ms, MDD-NonPsy = 82.1 ms), though the comparison was underpowered and did not reach significance (U = 15.0, p = 0.312; see Supplementary Table S2). In extended multiple regression models simultaneously controlling for antipsychotic medication status, antidepressant medication status, age, and sex, the group difference in microstate C duration remained significant (β = 6.12, 95% CI [1.24, 10.99], p = 0.015). Similarly, all altered transition probabilities remained significant after full covariate adjustment (B→C: β = −0.089, p < 0.001; C→A: β = −0.064, p = 0.005; C→B: β = 0.054, p = 0.012; D→C: β = −0.051, p = 0.020; Supplementary Table S3). Neither antipsychotic medication (β = 2.85, p = 0.329), antidepressant medication (β = −1.24, p = 0.629), age (β = −0.18, p = 0.261), nor sex (β = 1.42, p = 0.607) showed significant independent effects on microstate C duration, indicating that the observed group differences are not driven by these confounders.

Fig. 1.

Fig. 1

Group-level topographical maps of the four canonical EEG microstate classes (A–D). The maps represent the group-level template microstates derived from the resting-state EEG data of all participants (N = 131) by clustering the topographic maps at the peaks of the Global Field Power (GFP). The polarity of the maps is ignored. According to the literature, these canonical microstate classes are associated with distinct large-scale brain networks: microstate A with the auditory network, microstate B with the visual network, microstate C with the salience network, and microstate D with the attention/executive control network. The color scale represents arbitrary voltage values: red indicates positive voltage, blue indicates negative voltage, and intermediate colors (yellow/green/cyan) represent gradations between positive and negative. To confirm topographical comparability between diagnostic groups, spatial correlations (Pearson’s r across all 19 electrodes) were computed between group-level templates derived independently from MDD-Psy (n = 68) and MDD-NonPsy (n = 63) subgroups: class A: r = 0.94; class B: r = 0.96; class C: r = 0.97; class D: r = 0.93

Table 2.

Comparison of EEG Microstate Dynamics Between MDD-Psy and MDD-NonPsy Patients

Microstate Parameter MDD-NonPsy (n = 63) MDD-Psy (n = 68) Statistic p-value p-corr (FDR) Effect Size
Global Explained Variance (GEV) 0.74 ± 0.05 0.74 ± 0.05 t = 0.264 0.794 0.794 d = 0.05
Mean Duration, ms (Median [IQR])
Microstate A 88.62 [83.10, 95.54] 90.21 [78.16, 103.53] U = 1982.5 0.462 0.616 r_rb = 0.08
Microstate B 89.64 [80.94, 98.42] 86.59 [80.04, 96.91] U = 2042.0 0.645 0.645 r_rb = 0.04
Microstate C 85.56 [80.11, 95.14] 91.99 [87.93, 97.97] U = 1396.0 0.001 0.004** r_rb = 0.31
Microstate D 86.42 [79.69, 97.97] 85.43 [76.50, 94.89] U = 1886.0 0.238 0.476 r_rb = 0.14
Time Coverage (Median [IQR])
Microstate A 0.260 [0.230, 0.280] 0.249 [0.178, 0.314] U = 2040.0 0.638 0.851 r_rb = 0.04
Microstate B† 0.25 ± 0.05 0.25 ± 0.05 t = -0.096 0.924 0.924 d = 0.02
Microstate C 0.228 [0.200, 0.263] 0.263 [0.211, 0.308] U = 1628.0 0.018 0.072 r_rb = 0.22
Microstate D 0.238 [0.202, 0.310] 0.222 [0.171, 0.270] U = 1722.0 0.053 0.106 r_rb = 0.15
Occurrence, /s (Median [IQR])
Microstate A 2.85 [2.59, 3.08] 2.69 [2.28, 3.00] U = 1729.0 0.057 0.114 r_rb = 0.17
Microstate B 2.78 [2.10, 3.14] 2.84 [2.41, 3.09] U = 2111.0 0.886 0.886 r_rb = 0.02
Microstate C† 3.40 ± 0.40 3.28 ± 0.40 t = -1.263 0.209 0.279 d = 0.30
Microstate D† 3.31 ± 0.29 3.51 ± 0.29 t = 2.679 0.008 0.032* d = 0.47

Abbreviations: MDD-NonPsy, Major Depressive Disorder without psychotic features; MDD-Psy, Major Depressive Disorder with psychotic features; IQR, Interquartile Range (25th, 75th percentiles)

Note: Data are presented as Mean ± SD for normally distributed variables and Median [IQR] for non-normally distributed variables, based on Supplementary Table S1. † Variables analyzed using independent samples t-test (normally distributed). All other variables were analyzed using the Mann-Whitney U test (non-normally distributed)

p-corr: p-value after False Discovery Rate (FDR) correction using the Benjamini-Hochberg procedure within each test family (family size = 4 for duration, coverage, and occurrence). All p-corr values are capped at 1.0. * denotes significance after FDR correction (p-corr < 0.05). ** denotes high significance after correction

Altered microstate transition probabilities characterize psychotic depression

Analysis of transition probabilities between EEG microstates (detailed in Table 3) revealed distinct dynamic patterns between patients with MDD-Psy and those without (MDD-NonPsy). After FDR correction, significant group differences persisted in several transitions. Specifically, the probability of transitioning from microstate B→A was higher in the MDD-Psy group (median: 0.308) than in the MDD-NonPsy group (median: 0.267; p-corr = 0.006). Conversely, transitions from B→C were significantly lower in MDD-Psy (median: 0.302) compared to MDD-NonPsy (median:0.389; p-corr < 0.001). Similarly, the transition from C→A was lower (MDD-Psy median: 0.284 vs. MDD-NonPsy: 0.348; p-corr < 0.001), while the transition from C→B was higher in MDD-Psy (median: 0.341 vs. 0.287; p-corr < 0.001). The transition from D→C was also significantly reduced in the MDD-Psy group (mean: 0.35 ± 0.09) compared to the MDD-NonPsy group (mean: 0.40 ± 0.09; p-corr = 0.006). These results indicate a widespread reorganization of large-scale brain network dynamics in MDD with psychotic features, characterized by altered sequential activation patterns between specific microstate classes.

Table 3.

Comparison of transition probabilities between patients with MDD-Psy and MDD-NonPsy

Transition Probability (Median [IQR]) MDD-NonPsy (n = 63) MDD-Psy (n = 68) Statistic p-value p-corr (FDR) Effect Size
A → B 0.345 [0.295, 0.434] 0.316 [0.262, 0.381] U = 1728.0 0.057 0.098 r_rb = 0.17
B → A 0.267 [0.242, 0.304] 0.308 [0.250, 0.373] U = 1458.0 0.002 0.006** r_rb = 0.28
B → C 0.389 [0.334, 0.411] 0.302 [0.233, 0.349] U = 1035.0 < 0.001 0.001** r_rb = 0.42
B → D 0.352 [0.301, 0.391] 0.379 [0.326, 0.435] U = 1670.0 0.030 0.060 r_rb = 0.21
C → A 0.348 [0.283, 0.449] 0.284 [0.239, 0.330] U = 1155.5 < 0.001 0.001** r_rb = 0.38
C → B 0.287 [0.243, 0.313] 0.341 [0.278, 0.408] U = 1212.0 < 0.001 0.001** r_rb = 0.36
C → D 0.418 [0.368, 0.468] 0.398 [0.348, 0.448] U = 2045.5 0.353 0.385 r_rb = 0.08
D → A † 0.39 ± 0.10 0.42 ± 0.10 t = 1.913 0.058 0.098 d = 0.35
D → B 0.339 [0.298, 0.382] 0.342 [0.285, 0.388] U = 2061.5 0.711 0.711 r_rb = 0.03
D → C † 0.40 ± 0.09 0.35 ± 0.09 t = -3.114 0.002 0.006** d = 0.56
A → C † 0.34 ± 0.06 0.32 ± 0.06 t = -1.722 0.087 0.116 d = 0.31
A → D † 0.35 ± 0.08 0.33 ± 0.08 t = -1.157 0.249 0.299 d = 0.21

Abbreviations: MDD-NonPsy, Major Depressive Disorder without psychotic features; MDD-Psy, Major Depressive Disorder with psychotic features; IQR, Interquartile Range (25th, 75th percentiles)

Note: Data are presented as Mean ± SD for normally distributed variables and Median [IQR] for non-normally distributed variables, based on Supplementary Table S1. † Variables analyzed using independent samples t-test (normally distributed: A→C, A→D, D→A, D→C; Shapiro-Wilk p > 0.05). All other variables were analyzed using the Mann-Whitney U test (non-normally distributed: A→B, B→A, B→C, B→D, C→A, C→B, C→D, D→B; Shapiro-Wilk p < 0.05)

p-corr: p-value after False Discovery Rate (FDR) correction using the Benjamini-Hochberg procedure within the transition probability family (family size = 12). All p-corr values are capped at 1.0. * denotes significance after FDR correction (p-corr < 0.05). ** denotes high significance after correction

Salience network microstate transitions show robust correlations with psychotic symptoms

To examine the relationship between altered microstate parameters and psychotic symptom severity, we first computed partial Spearman correlations in the combined sample, controlling for diagnostic group, antipsychotic medication status, antidepressant medication status, age, and sex. Results are summarized in Table 4. The most robust finding was the negative correlation between the B → C transition probability and both the BPRS Thought Disturbance score (partial ρ = −0.298, 95% CI [− 0.456, − 0.128], p = 0.001, p-FDR = 0.006) and the BPRS Hostility score (partial ρ = −0.264, 95% CI [− 0.426, − 0.091], p = 0.003, p-FDR = 0.012; Supplementary Table S4, Panel A). The reverse transition (C → B) showed positive correlations with these symptom domains (Thought Disturbance: partial ρ = 0.276, 95% CI [0.102, 0.434], p = 0.002, p-FDR = 0.008; Hostility: partial ρ = 0.198, 95% CI [0.022, 0.363], p = 0.028, p-FDR = 0.084). The C → A transition was negatively correlated with Thought Disturbance (partial ρ = −0.258, 95% CI [− 0.421, − 0.084], p = 0.004, p-FDR = 0.012).Of secondary interest, the mean duration of microstate C showed a positive correlation with Thought Disturbance in the unadjusted combined-sample analysis (ρ = 0.243, p-FDR = 0.030), but this association was attenuated and became non-significant after controlling for group and other covariates (partial ρ = 0.142, p = 0.112), suggesting that it was partially driven by diagnostic group differences. To further verify that these associations reflect genuine symptom severity variation rather than mere group differences, we computed within-group correlations in the MDD-Psy group alone (n = 68). The B → C transition showed a significant negative correlation with thought disturbance (ρ = −0.312, p = 0.010) and a trend-level association with hostility (ρ = −0.238, p = 0.054; Supplementary Table S4, Panel B). The C → B transition correlated positively with thought disturbance (ρ = 0.298, p = 0.014). These within-group findings confirm that the associations are observable within the psychotic depression subtype itself, though the reduced sample size limits statistical power. Collectively, these three analytical approaches—combined-sample unadjusted, combined-sample covariate-adjusted, and within-group—converge on the B → C transition as the most robust psychophysiological correlate of psychotic symptom severity.

Table 4.

Correlations between altered EEG microstate parameters and psychotic symptom severity in All MDD Patients (N = 131)

Microstate
Parameter
Associated
Network
Clinical Scale
(BPRS)
Spearman’s
ρ
95% CI p-value p-FDR p-Bonferroni
Mean Duration C Salience Network Thought Disturbance 0.243 [0.075, 0.394] 0.005 0.030* 0.060
Mean Duration C Salience Network Hostility 0.172 [0.001, 0.334] 0.050 0.150 0.600
B → C Visual → Salience Thought Disturbance -0.393 [-0.528, -0.237] < 0.001 < 0.001* < 0.012*
B → C Visual → Salience Hostility -0.357 [-0.497, -0.197] < 0.001 0.003* < 0.012*
C → A Salience → Auditory Thought Disturbance -0.347 [-0.489, -0.187] < 0.001 0.003* < 0.012*
C → A Salience → Auditory Hostility -0.185 [-0.345, -0.014] 0.034 0.102 0.408
C → B Salience → Visual Thought Disturbance 0.364 [0.205, 0.503] < 0.001 0.003* < 0.012*
C → B Salience → Visual Hostility 0.238 [0.069, 0.393] 0.006 0.018* 0.072
D → C Executive Control → Salience Thought Disturbance 0.156 [-0.016, 0.318] 0.076 0.152 0.912
D → C Executive Control → Salience Hostility 0.096 [-0.077, 0.263] 0.273 0.364 1.000
Occurrence D Executive Control Network Thought Disturbance -0.175 [-0.336, -0.004] 0.045 0.135 0.540
Occurrence D Executive Control Network Hostility -0.043 [-0.214, 0.129] 0.628 0.698 1.000

Abbreviations: BPRS, Brief Psychiatric Rating Scale

Note: Network associations are based on canonical mapping: Microstate C (Salience Network), B (Visual Network), A (Auditory Network), D (Executive Control Network). p-FDR denotes the p-value after False Discovery Rate correction for multiple comparisons (12 tests: 6 EEG parameters × 2 clinical scales). p-Bonferroni denotes the p-value after Bonferroni correction (α = 0.05/12 = 0.0042). 95% CI = 95% confidence interval for Spearman’s ρ computed via Fisher z-transformation. * indicates significance after the respective correction (p < 0.05 for FDR; p < 0.0042 for Bonferroni)

Discussion

The present study characterized aberrant resting-state EEG microstate dynamics in MDD-Psy, revealing a potentially distinct pattern of large-scale brain network dynamics relative to non-psychotic depression. The principal finding was a significantly prolonged duration of microstate C, a topographic pattern that prior multimodal work has associated with salience network dynamics, in MDD-Psy patients (91.99 ms) relative to MDD-NonPsy controls (85.56 ms). Additionally, psychotic depression exhibited a reconfigured temporal architecture characterized by altered transition probabilities between canonical microstates, including increased B→A transitions and decreased B→C and C→A transitions. Critically, these neurophysiological alterations demonstrated clinically meaningful relationships with psychotic symptom dimensions: microstate C duration correlated positively with thought disturbance severity, while the diminished B→C transition probability showed robust negative correlations with both thought disturbance and hostility. These findings provide empirical support for dysregulated salience network dynamics as a core neurophysiological feature of psychotic depression, linking aberrant brain temporal organization directly to the expression of psychotic symptoms.

While the aberrant salience hypothesis provides a valuable transdiagnostic framework, it risks obscuring the phenomenological specificity of psychotic depression if applied generically. A critical cognitive dimension that distinguishes affective psychosis from primary psychotic disorders is the role of maladaptive emotion regulation, particularly rumination, as a pathogenic mechanism. In MDD-Psy, delusional ideation and thought disturbance often emerge not de novo but through the rigid entrenchment of negative self-referential processing, wherein ruminative loops become so perseverative that they distort reality testing [3, 45]. Our microstate findings can be reinterpreted within this affective neuroscience framework, offering a mechanistically richer account than schizophrenia-derived models alone.

The prolongation of microstate C duration in MDD-Psy may reflect the salience network’s pathological engagement with internally generated ruminative content. In this view, the salience network does not merely misattribute significance to external neutral stimuli (as classically proposed for schizophrenia); rather, it becomes chronically occupied by the self-salience of depressive rumination, assigning aberrant significance to internally generated negative thoughts and autobiographical memories. This internal hyper-focus would manifest neurophysiologically as prolonged stability of the salience network configuration (microstate C), effectively “locking” processing resources into a closed self-referential loop. This interpretation converges with recent electrophysiological evidence demonstrating that individuals with high ruminative tendencies exhibit decreased frontal EEG complexity (frequency-specific entropy reduction), indicating a restricted, perseverative information-processing mode [46]. The reduced neural complexity observed in ruminators parallels the prolonged temporal stability of microstate C in our MDD-Psy patients—both suggesting a loss of flexible, dynamic network exploration in favor of rigid, self-focused states.

The diminished B→C transition probability acquires a specific meaning within this ruminative framework: it reflects the suppression of external visual information processing by internally directed attention. When the salience network is monopolized by ruminative self-focus, perceptual inputs from the visual network (microstate B) fail to gain access to salience evaluation and reality monitoring. This creates a functional decoupling in which the external world is progressively excluded from conscious processing, providing a neurophysiological substrate for the detachment from reality and delusional misinterpretation characteristic of psychotic depression. This mechanism aligns with findings that opposing emotion regulation strategies—rumination versus cognitive distraction—exhibit markedly distinct spectral coherence architectures, with ruminative states reorganizing inter-regional communication to prioritize internal over external information streams [47].

The neuroscientific interpretation of diminished B→C transitions warrants careful dissection of whether this represents an active pathological defense mechanism or a structural breakdown in network coordination secondary to chronic rumination. We propose that both processes operate sequentially and may be distinguishable along a temporal and severity gradient.

Initially, the B→C decoupling likely reflects an active, albeit maladaptive, defensive process. In the context of severe depressive affect, the salience network may deliberately withdraw from processing external visual input to protect and sustain internally directed ruminative focus. This is consistent with the phenomenology of psychotic depression, wherein patients describe an overwhelming, involuntary preoccupation with negative self-referential thoughts that actively excludes external reality. From a regulatory perspective, this represents a failed emotion regulation strategy: rather than flexibly deploying attention to modulate affect, the system becomes rigidly entrenched in a self-perpetuating loop of internal processing. The negative correlation between B→C transition probability and hostility severity (ρ = −0.357) supports this interpretation—higher hostility, often reflecting externalized frustration with reality intrusion, is associated with more complete visual-salience decoupling, suggesting an active defensive exclusion of the external world.

However, with chronicity and severity, this functional withdrawal may progress to structural breakdown in salience network gating capacity. The robust correlation between B→C transitions and thought disturbance (ρ = −0.393)—the core psychotic symptom dimension encompassing delusional ideation and conceptual disorganization—suggests that prolonged decoupling is not merely strategic but reflects a degraded capacity to re-engage external input even when adaptive. This aligns with Aydın & Akın’s (2022) finding of decreased frontal EEG complexity in chronic ruminators: reduced entropy indicates a loss of dynamic range in information processing, paralleling the rigid, non-flexible microstate dynamics we observe. The salience network, chronically deprived of external visual input, may undergo use-dependent plasticity changes that progressively impair its gating function—a mechanism akin to learned non-use in motor systems, but applied to perceptual-salience integration.

The distinction between defense mechanism and structural breakdown is further illuminated by the asymmetric transition reconfiguration. The reciprocal increase in C→B transitions (while B→C decreases) suggests that information flow is not uniformly blocked but pathologically rerouted: the salience network actively projects internally generated signals back to visual processing, potentially generating the vivid, self-referential visual imagery and reality-distorting percepts reported in psychotic depression. This unidirectional rerouting—outflow without inflow—mirrors the assortativity reduction documented in ruminative brain networks by Aydın (2023), wherein diminished network resilience reflects impaired reciprocal coordination between systems. The C→A decrease (salience-to-auditory disengagement), in contrast, may represent a more primary structural deficit, as auditory processing lacks the compensatory back-projection seen in the visual domain.

Synthesizing these perspectives, we interpret the B→C transition decrease as a dynamic process with two phases: (i) an early, functional phase of active defensive withdrawal driven by overwhelming ruminative self-focus, and (ii) a later, structural phase of degraded salience gating capacity resulting from chronic disuse and network plasticity maladaptation. In our cross-sectional sample, patients likely represent varying points along this continuum, with the severity-dependent correlations (stronger for thought disturbance than hostility) suggesting that more psychotic individuals have progressed further toward structural breakdown. Longitudinal studies tracking microstate dynamics from acute depressive episodes through chronic psychotic depression would be essential to validate this proposed temporal trajectory and to determine whether early intervention targeting ruminative processes could prevent the progression from functional defense to structural network damage.

Furthermore, the asymmetric reconfiguration of transitions—increased C→B but decreased C→A—resonates with models of global network dysregulation during persistent negative self-referential thought. Rather than reflecting a uniform disconnection, this pattern suggests a pathological rerouting in which the salience network aberrantly projects signals back to visual processing (C→B increase) while disengaging from auditory processing (C→A decrease). This asymmetry may mirror the inter-hemispheric and inter-network coordination deficits documented in ruminative profiles. Recent graph-theoretic analyses of resting-state EEG have shown that frequent rumination is associated with reduced assortativity and disrupted segregation-integration balance—topological alterations indicating diminished network resilience and impaired flexible coordination between large-scale systems [48]. In our data, the altered transition syntax (particularly the reciprocal B→C/C→B dysregulation) may represent the temporal dynamic counterpart to these topological changes: a rigid, perseverative pattern of network switching that prevents the flexible reallocation of processing resources required for adaptive emotion regulation.

Collectively, this reframing positions the microstate alterations in MDD-Psy within a coherent affective-cognitive pathophysiology: psychotic symptoms in depression emerge when maladaptive rumination, sustained by prolonged salience network activity and reinforced by decoupled visual-salience transitions, becomes so entrenched that it overrides reality testing. This perspective shifts the narrative away from a generic “schizophrenia-like psychosis” model and firmly anchors our findings in the specific domain of affective psychosis, where the co-occurrence of mood disturbance and reality distortion is mechanistically linked to dysregulated self-referential processing rather than primary sensory-limbic disconnection.

The current findings both converge with and diverge from prior microstate research across psychotic disorders, highlighting the unique neurophysiological signature of psychotic depression. Our observation of prolonged microstate C duration in MDD-Psy aligns with studies reporting increased microstate C contribution in clinical high-risk and first-episode psychosis [17], and is consistent with the hypothesis that microstate C alterations reflect aberrant salience network functioning [15]. However, this pattern contrasts with findings in treated schizophrenia, where microstate C parameters may normalize or show negative correlations with negative symptoms [39], suggesting that medication status and clinical phase critically influence microstate dynamics. The altered transition probabilities we observed, particularly the reduced B→C and C→A transitions, support recent transdiagnostic evidence of impaired network switching between visual, salience, and auditory networks across psychotic and mood disorders [40]. This finding extends earlier work demonstrating microstate syntax disturbances in first-episode schizophrenia [16], suggesting that transition abnormalities represent a shared feature of psychosis spectrum conditions. Notably, our direct comparison of MDD-Psy and MDD-NonPsy reveals a specificity not captured in previous studies, as microstate D—frequently reported as decreased in schizophrenia and high-risk states [17, 41]—showed only nominal differences between our depression groups, reinforcing that the microstate C prolongation rather than D reduction distinguishes psychotic from non-psychotic depression. This distinction is further supported by resting-state fMRI data from psychotic depression demonstrating decreased frontoparietal network connectivity [42], which may represent a complementary imaging correlate of the altered temporal dynamics observed here. The correlation between the B → C transition probability and psychotic symptom severity (ρ = -0.393 for thought disturbance) represents a medium effect size and was the most robust finding in our exploratory analyses, surviving both FDR and Bonferroni correction. An important methodological consideration is whether the observed symptom-microstate correlations in the combined sample merely reflect the strong diagnostic group differences in both variables (i.e., MDD-Psy patients have higher BPRS scores and altered microstates compared to MDD-NonPsy patients). Our supplementary analyses directly address this concern. First, when diagnostic group and other covariates were controlled in partial correlation models, the B → C transition remained significantly associated with thought disturbance and hostility, demonstrating that this association is not purely an artifact of group dichotomy. Second, within-group correlations in the MDD-Psy sample alone replicated the direction and approximate magnitude of the B → C and C → B associations, confirming that these relationships reflect genuine symptom severity variation within the psychotic subtype. However, the microstate C duration association with thought disturbance did not survive covariate adjustment, suggesting that this weaker finding was indeed partially confounded by group membership. We have therefore conservatively interpreted the microstate C duration correlation as tentative, while presenting the B → C transition as the most robust and replicated finding across all analytical approaches. This association is theoretically meaningful: a reduced propensity to switch from visual processing (microstate B) to salience detection (microstate C) may reflect a fundamental disruption in how external perceptual information is integrated into the salience network in psychotic depression, potentially contributing to the misattribution of salience characteristic of psychotic symptoms. The positive correlation between microstate C duration and thought disturbance (ρ = 0.243) was weaker and did not survive Bonferroni correction; we therefore interpret this as a tentative, hypothesis-generating finding that requires replication in larger, medication-naïve samples. It is important to emphasize that all correlation analyses in this study were exploratory and should not be overinterpreted as establishing causal or clinically predictive relationships. Collectively, our results position MDD-Psy as exhibiting a hybrid microstate pattern: sharing certain features with primary psychotic disorders while maintaining distinct characteristics that differentiate it from both schizophrenia and non-psychotic depression.

The present study advances the field through several methodological innovations that differentiate it from prior work. First, our direct comparison of MDD-Psy and MDD-NonPsy groups, rather than the conventional patient-control designs employed in schizophrenia research [16, 17], isolates neurophysiological features specific to psychotic features rather than depression broadly. The correlation analyses revealed a differential pattern of association strength between microstate dynamics and psychotic symptom dimensions. The most robust finding was the negative correlation between the B → C transition probability and both thought disturbance and hostility severity. This association survived both FDR and Bonferroni correction, representing a medium effect size (|ρ| ≈ 0.35–0.39) that is unlikely to reflect spurious correlation inflation. Theoretically, a reduced propensity to switch from visual network processing (microstate B) to salience network engagement (microstate C) may reflect a fundamental disruption in how external perceptual information is integrated into the salience evaluation system in psychotic depression. This “decoupling” of visual input from salience attribution could mechanistically contribute to the misattribution of salience and reality distortion characteristic of psychotic symptoms [15, 43]. The reciprocal increase in C → B transitions further supports this interpretation, suggesting a bidirectional dysregulation in which the salience network not only fails to appropriately receive visual input but also aberrantly redirects signals back to visual processing.

In contrast, the positive correlation between microstate C duration and thought disturbance, while nominally significant after FDR correction, did not survive Bonferroni correction and represents a small effect size (ρ = 0.243). We therefore interpret this association as tentative and hypothesis-generating rather than conclusive. It is possible that prolonged salience network stability contributes to thought disturbance severity, but the modest effect size and failure to withstand the most stringent multiple comparison correction suggest that this relationship requires replication in larger, ideally medication-naïve samples before it can be considered a reliable candidate marker. Notably, the absence of a significant correlation between microstate C duration and hostility further supports the specificity of the B → C transition as the more robust psychophysiological marker.

This differential robustness has important implications for the theoretical interpretation of our findings. The transition-based measures (B → C, C → B, C → A) capture the dynamic syntax of network interactions—the sequential rules governing how large-scale brain configurations switch and influence one another [16, 19]. These dynamic parameters may be more sensitive to the pathophysiological disruptions underlying psychosis than static measures such as mean duration, which reflect only the temporal stability of a single network state. Our results align with emerging transdiagnostic evidence that impaired network switching, rather than isolated network hyperactivity or hypoactivity, constitutes the core neurophysiological signature of psychosis spectrum conditions [40]. The medium effect sizes observed for transition correlations (|ρ| = 0.35–0.39) are consistent with prior microstate-symptom associations in first-episode schizophrenia and clinical high-risk populations [16, 19], suggesting that our findings are not outliers but rather fit within the established effect size range for this literature.

The robust association between salience network microstate dynamics and psychotic symptoms also resonates with studies linking microstate C to aberrant salience processing across psychiatric disorders [15, 43] and with treatment response prediction in schizophrenia [39] and depression [44]. Our findings underscore the utility of microstate analysis as a translational candidate marker tool that bridges the gap between phenomenology and pathophysiology in affective psychosis, offering a temporal precision that complements structural and functional neuroimaging studies in psychotic depression [4]. Furthermore, the clinical stratification using both KDAS and BPRS dimensions represents a more nuanced approach than prior studies relying solely on diagnostic categories, echoing recent calls for dimensional assessment across psychiatric disorders [3, 45].

The most important limitation of this study is the inability to fully disentangle disease-specific microstate alterations from the effects of antipsychotic medication. Patients with psychotic depression were more frequently treated with antipsychotics (69.1%) than non-psychotic patients (19.0%), reflecting clinical necessity. Antipsychotic medications are known to induce measurable alterations in brain structure and functional connectivity in patients with psychotic depression [4], raising the possibility that observed microstate differences could partially reflect pharmacological rather than pathophysiological effects. However, several considerations argue against medication as the sole explanation. First, in supplementary ANCOVA models, the group differences in microstate C duration and transition probabilities remained significant after controlling for antipsychotic medication status as a binary covariate (all p-corr < 0.05), and there was no significant group × medication interaction (F = 1.34, p = 0.249; Supplementary Table S2). Second, the medication-naïve subsample, though underpowered (n = 14), showed a consistent direction of effects with the full sample (Supplementary Table S2). Third, prior microstate research in psychosis populations has demonstrated that microstate D—rather than microstate C—shows the strongest sensitivity to medication status and clinical phase [17], suggesting that microstate C prolongation may reflect a more stable, disease-related characteristic. Fourth, the robust correlation between microstate C duration and thought disturbance severity, which remained significant after controlling for medication status, would not be expected if the finding were a pure pharmacological artifact. Nevertheless, we acknowledge that without systematic dose recording (e.g., chlorpromazine equivalents) or a prospective medication-naïve design, medication effects cannot be fully excluded. Future longitudinal studies enrolling drug-naïve patients prior to treatment initiation are essential to confirm these findings as trait markers of psychotic depression. Second, illness duration and educational level were not systematically recorded or controlled in this study. Both variables may influence EEG microstate dynamics: longer illness duration may be associated with neuroprogressive alterations in large-scale network function, while educational level may proxy for cognitive reserve and premorbid functioning. Although the two groups were matched for age and sex, the absence of these covariates precludes a fully adjusted analysis. Future prospective studies should record illness duration from illness onset and years of education to determine whether the observed microstate alterations are moderated by clinical chronicity or cognitive reserve. Third, the absence of a healthy control group limits our ability to contextualize the observed microstate alterations relative to normative brain dynamics. We cannot determine whether the prolonged microstate C duration and altered transition probabilities observed in MDD-Psy represent a specific marker of psychotic features within depression, a general feature of all MDD patients, or a deviation from healthy brain function shared across psychiatric conditions. This case-case design was chosen to directly isolate the neurophysiological features distinguishing psychotic from non-psychotic depression, but a three-group design incorporating healthy controls is essential to disentangle disease-specific from subtype-specific alterations. We have therefore tempered our conclusions to avoid claims of specificity relative to healthy function. Fourth, the cross-sectional design precludes establishing causal relationships between microstate dynamics and psychotic symptoms, nor can we determine whether these alterations represent state-dependent markers of acute psychosis or trait vulnerability markers [39]. Fifth, our sample was recruited from a single clinical setting with specific demographic characteristics, which may limit generalizability to other populations or cultural contexts. Sixth, the 19-channel EEG system, while standard for clinical microstate analysis, offers limited spatial resolution compared to high-density systems. An important caveat in interpreting our findings is the limited spatial resolution of 19-channel scalp EEG. While the association between microstate C and the salience network is supported by converging evidence from EEG-fMRI simultaneous recordings and source-localization studies [15, 18, 36], our scalp topography data cannot directly confirm this network attribution. High-density EEG systems or combined EEG-fMRI approaches would be needed to more precisely localize the neural generators of the observed microstate alterations. We have therefore used cautious phrasing throughout the manuscript (e.g., ‘putatively associated with,’ ‘commonly linked to’) to reflect this indirect mapping. Additionally, the 100 Hz sampling rate limits temporal resolution to 10 ms, which may introduce quantization effects in transition probability estimation, particularly for microstate durations approaching the lower end of the typical 60–120 ms range. While our GFP peak detection algorithm (minimum inter-peak interval: 10 ms) and the observed median durations (~ 86–92 ms) suggest that this resolution is adequate for capturing dominant microstate dynamics, future studies employing higher sampling rates (e.g., 500–1000 Hz) could refine transition probability estimates and reduce potential discretization artifacts.

Future directions should encompass longitudinal investigations assessing microstate stability across illness phases and treatment interventions to differentiate state versus trait markers, following patients from acute psychotic depression through remission, alongside multimodal integration combining EEG microstates with fMRI connectivity measures to provide complementary temporal and spatial resolution, elucidating how millisecond-level network dynamics relate to longer-timescale functional connectivity disruptions observed in psychotic depression [15, 42]. Machine learning approaches should be developed to validate microstate parameters as diagnostic candidate markers, potentially enabling early identification of psychotic features in depression and predicting treatment response, as demonstrated in recent schizophrenia and epilepsy studies [39, 26, 49], while transdiagnostic extensions examining microstate patterns across schizophrenia, bipolar disorder, and psychotic depression could clarify whether the observed microstate C prolongation represents a psychosis spectrum marker or a depression-specific phenomenon [40, 41, 43]. Additionally, sleep EEG protocols should be implemented, as recent work demonstrates that microstate abnormalities differ between wake and sleep states in schizophrenia, potentially revealing novel candidate markers and therapeutic targets [50], and intervention studies manipulating salience network function through pharmacological or neuromodulatory approaches could test whether normalizing microstate C dynamics reduces psychotic symptoms, building on treatment prediction models in depression [44]. Microstate analysis and graph‑theoretic connectivity offer complementary views: the former captures temporal dynamics of global brain configurations, while the latter quantifies pairwise connectivity and network topology [30–32]. Beyond graph-theoretic connectivity, future studies should explicitly incorporate interhemispheric synchronization and signal complexity metrics to fully capture the neurophysiological dynamics of psychotic depression. Interhemispheric synchronization measures—including spectral coherence, phase-locking value, and mutual information—are essential given the documented interhemispheric dysregulation in ruminative states [47] and the potential hemispheric asymmetry in microstate transitions observed in our data (e.g., differential C→B vs. C→A patterns). These metrics would directly test whether the disrupted visual-salience coupling (B→C) is accompanied by systematic interhemispheric decoupling, particularly within frontoparietal regions implicated in salience evaluation. Furthermore, signal complexity measures—such as multiscale entropy, Lempel-Ziv complexity, and frequency-specific complexity (FSC)—should be applied to the same 19-channel datasets to quantify the reduced neural complexity associated with rigid, perseverative microstate dynamics. The documented decrease in frontal EEG complexity among chronic ruminators suggests that microstate prolongation and entropy reduction may represent complementary markers of the same pathological rigidity [46]. Integrating these approaches would provide a more comprehensive neurophysiological portrait of psychotic depression, bridging global network dynamics (microstate transitions), interhemispheric coordination, and local information-processing capacity within a unified analytical framework.

Microstate analysis and graph‑theoretic connectivity offer complementary views: the former captures temporal dynamics of global brain configurations, while the latter quantifies pairwise connectivity and network topology [30–32]. Recent studies have successfully applied graph‑theoretic analysis to resting‑state EEG in depression, revealing altered network properties [51]. A natural next step is to apply graph‑theoretic connectivity analysis to the same 19‑channel EEG dataset to examine whether prolonged microstate C duration relates to altered salience network connectivity, and whether altered transition probabilities (e.g., reduced B→C) correspond to specific inter‑network changes. Such integration would deepen understanding of network‑level correlates in psychotic depression.

Recent studies have successfully applied graph‑theoretic analysis to resting‑state EEG in depression, revealing altered network properties [48]. A natural next step is to apply graph‑theoretic connectivity analysis to the same 19‑channel EEG dataset to examine whether prolonged microstate C duration relates to altered salience network connectivity, and whether altered transition probabilities (e.g., reduced B→C) correspond to specific inter‑network changes. Such integration would deepen understanding of network‑level correlates in psychotic depression.

The most critical limitation is the potential confounding effect of antipsychotic medication. MDD-Psy patients were more frequently medicated with antipsychotics (69.1% vs. 19.0%), and these agents are known to alter EEG microstates non-specifically. However, three lines of evidence argue against medication as the sole explanation: (i) the group differences in microstate C duration and transition probabilities remained significant after controlling for medication status in ANCOVA (all p-corr < 0.05); (ii) no significant group × medication interaction was observed (F = 1.34, p = 0.249); and (iii) the medication-naïve subsample showed consistent effect directions, albeit underpowered (Supplementary Table S2). Nonetheless, without systematic dose recording or a drug-naïve design, medication effects cannot be fully excluded. Additional limitations include the cross-sectional design (precluding causal/state-trait inferences), single-site recruitment, 19-channel spatial resolution, and the absence of a healthy control group. The 100 Hz sampling rate limits temporal resolution to 10 ms, which may introduce quantization effects in transition probability estimation, particularly for microstate durations approaching the lower end of the typical 60–120 ms range. While our GFP peak detection algorithm (minimum inter-peak interval: 10 ms) and the observed median durations (~ 86–92 ms) suggest that this resolution is adequate for capturing dominant microstate dynamics, future studies employing higher sampling rates (e.g., 500–1000 Hz) could refine transition probability estimates and reduce potential discretization artifacts.

Conclusions

Psychotic depression represents a severe clinical subtype of major depressive disorder associated with distinct alterations in large-scale brain network dynamics. Within this case-case comparison, patients with MDD-Psy exhibited prolonged salience network activity (indexed by microstate C duration) and reconfigured temporal transitions between the salience, visual, and auditory networks relative to patients with MDD-NonPsy. The most robust finding was the altered transition probability from the visual network to the salience network (B → C), which showed medium-effect-size correlations with core psychotic symptom dimensions including thought disturbance and hostility, surviving both FDR and Bonferroni correction. These findings suggest that dysregulated dynamic coupling between perceptual processing and salience evaluation may constitute a neurophysiological correlate of psychotic features within depression.

However, these results should be interpreted with considerable caution. First, the cross-sectional design and the high rate of antipsychotic medication use in the MDD-Psy group preclude a tentative causal attribution to the disease process alone; while supplementary analyses controlling for medication status preserved the group differences, a medication-naïve design is required to confirm these findings as trait markers. Second, the absence of a healthy control group limits our conclusions to differences between MDD subtypes rather than abnormalities relative to normative brain function; we cannot determine whether the observed microstate alterations are specific to psychotic depression, generalizable to all MDD patients, or shared with other psychiatric conditions. Third, illness duration and educational level were not systematically recorded, precluding full adjustment for potential clinical and developmental confounders. Fourth, the correlation between microstate C duration and thought disturbance, while nominally significant, represented a small effect size and did not survive the most stringent multiple comparison correction; this association should be considered tentative and hypothesis-generating. Finally, microstate analysis captures global network configuration dynamics but does not resolve the underlying spectral power shifts or local oscillatory mechanisms; integration with complementary EEG signal processing approaches will be essential to move from descriptive correlation toward hypothesized mechanism.

At present, our findings contribute to a hypothesized mechanistic framework for psychotic depression by identifying reconfigured temporal syntax between large-scale brain networks as a candidate neurophysiological signature distinguishing MDD-Psy from MDD-NonPsy. Validation in longitudinal, medication-naïve samples with healthy controls is required before clinical translation can be considered. Future longitudinal studies enrolling medication-naïve patients, incorporating healthy controls, and combining microstate analysis with spectral and complexity markers are required to validate whether these dynamic network alterations can serve as reliable, potentially clinically informative candidate markers for the identification and prognostication of psychotic features in depression.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (19.2KB, docx)
Supplementary Material 2 (31.9KB, docx)
Supplementary Material 4 (31.7KB, docx)

Acknowledgements

This study was supported by the Zigong Key Science and Technology Program (No. 2023-NKY-02-11). The authors gratefully acknowledge the clinical assessment teams at Zigong Mental Health Center, Chengdu Jinxin Brain Hospital, and the Affiliated Hospital of Southwest Medical University for their diligent work in participant recruitment, diagnostic evaluations, and data collection. We extend our sincere appreciation to the EEG technicians and research coordinators who ensured high-quality data acquisition. Most importantly, we thank all patients who participated in this study and their families for their invaluable contribution and trust. The authors declare that there are no conflicts of interest.

Author contributions

Yu Yang: Conducted EEG data acquisition and preprocessing, performed microstate analysis, contributed to data interpretation, and drafted the manuscript. Dexin Liao: Contributed to study design, conducted clinical assessments and EEG recordings, participated in data analysis and interpretation, and revised the manuscript. Yudiao Liang: Conducted clinical assessments, recruited participants, and contributed to data collection. Yanping Feng: Conducted clinical assessments, coordinated participant enrollment, and contributed to data collection. Shanhong Wang: Conducted clinical assessments, managed clinical data, and contributed to participant follow-up. Sha Zhang: Conducted clinical assessments, assisted with EEG data acquisition, and contributed to data collection. Kezhi Liu: Conceived and designed the study, secured funding, supervised all aspects of the research, contributed to data interpretation, and revised the manuscript critically for intellectual content. Kezhi Liu is the corresponding author and accepts full responsibility for the work and the conduct of the study, had access to the data, and controlled the decision to publish. All authors read and approved the final manuscript.

Funding

This project was supported by the Key Science and Technology Program of Zigong City (2023-NKY-02-11).

Data availability

The datasets generated and analyzed during the current study are not publicly available due to patient confidentiality and ethical restrictions but are available from the corresponding author on reasonable request, subject to approval by the institutional ethics committee of Zigong Mental Health Center.

Declarations

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yu Yang and Dexin Liao contributed equally to this work.

References

  • 1.Dubovsky SL, Ghosh BM, Serotte JC, Cranwell V. Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment. Psychother Psychosom. 2021;90(3):160–77. [DOI] [PubMed] [Google Scholar]
  • 2.Xin LM, Su YA, Yan F, et al. Prevalence, clinical features and prescription patterns of psychotropic medications for patients with psychotic depression in China. J Affect disorders Mar. 2022;15:301:248–52. [DOI] [PubMed] [Google Scholar]
  • 3.Cavallotti S, Castelnovo A, Ranieri R, D’Agostino A. Stability of cognition across wakefulness and dreams in psychotic major depression. Psychiatry Res Apr. 2014;30(1):31–6. [DOI] [PubMed] [Google Scholar]
  • 4.Voineskos AN, Mulsant BH, Dickie EW, et al. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial. JAMA psychiatry Jul. 2020;1(7):674–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ihaddadene RA, Alexopoulos GS, Marino P, et al. Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial. Psychiatry Res Dec. 2024;342:116192. [DOI] [PubMed] [Google Scholar]
  • 6.Sankaranarayanan A, Mancuso S, Castle D. Smoking and suicidality in patients with a psychotic disorder. Psychiatry Res Mar. 2014;30(3):634–40. [DOI] [PubMed] [Google Scholar]
  • 7.Kaiser RH, Andrews-Hanna JR, Wager TD, Pizzagalli DA. Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity. JAMA psychiatry Jun. 2015;72(6):603–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mulders PC, van Eijndhoven PF, Schene AH, Beckmann CF, Tendolkar I. Resting-state functional connectivity in major depressive disorder: A review. Neuroscience and biobehavioral reviews. Sep. 2015;56:330–44. [DOI] [PubMed] [Google Scholar]
  • 9.Hamilton JP, Farmer M, Fogelman P, Gotlib IH. Depressive Rumination, the Default-Mode Network, and the Dark Matter of Clinical Neuroscience. Biological psychiatry. Aug. 2015;15(4):224–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kaiser RH, Whitfield-Gabrieli S, Dillon DG, et al. Dynamic Resting-State Functional Connectivity in Major Depression. Neuropsychopharmacology: official publication Am Coll Neuropsychopharmacol Jun. 2016;41(7):1822–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Demirtaş M, Tornador C, Falcón C, et al. Dynamic functional connectivity reveals altered variability in functional connectivity among patients with major depressive disorder. Hum brain Mapp Aug. 2016;37(8):2918–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Newson JJ, Thiagarajan TC. EEG Frequency Bands in Psychiatric Disorders: A Review of Resting State Studies. Front Hum Neurosci. 2018;12:521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.de Aguiar Neto FS, Rosa JLG. Depression candidate markers using non-invasive EEG: A review. Neurosci biobehavioral reviews Oct. 2019;105:83–93. [DOI] [PubMed] [Google Scholar]
  • 14.Kadier N, Stein M, Koenig T. EEG Microstates and Psychosocial Stress During an Exchange Year. Brain topography Mar. 2021;34(2):117–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nishida K, Morishima Y, Yoshimura M, et al. EEG microstates associated with salience and frontoparietal networks in frontotemporal dementia, schizophrenia and Alzheimer’s disease. Clin neurophysiology: official J Int Federation Clin Neurophysiol Jun. 2013;124(6):1106–14. [DOI] [PubMed] [Google Scholar]
  • 16.Lehmann D, Faber PL, Galderisi S, et al. EEG microstate duration and syntax in acute, medication-naive, first-episode schizophrenia: a multi-center study. Psychiatry Res Feb. 2005;28(2):141–56. [DOI] [PubMed] [Google Scholar]
  • 17.Liebrand M, Katsarakis A, Josi J, et al. EEG microstate D as psychosis-specific correlate in adolescents and young adults with clinical high risk for psychosis and first-episode psychosis. Schizophrenia Res Feb. 2024;264:49–57. [DOI] [PubMed] [Google Scholar]
  • 18.Soni S, Muthukrishnan SP, Sood M, Kaur S, Sharma R. Hyperactivation of left inferior parietal lobule and left temporal gyri shortens resting EEG microstate in schizophrenia. Schizophrenia research. Nov. 2018;201:204–7. [DOI] [PubMed] [Google Scholar]
  • 19.Tomescu MI, Rihs TA, Becker R, et al. Aug. Deviant dynamics of EEG resting state pattern in 22q11.2 deletion syndrome adolescents: a vulnerability marker of schizophrenia? Schizophr Res. 2014;157(1–3):175–81. [DOI] [PubMed]
  • 20.Luo Y, Shen Y, Fan X. EEG microstates in adolescent depression: Effects of depression severity and overall symptoms. J Affect disorders Dec. 2025;1:390:119819. [DOI] [PubMed] [Google Scholar]
  • 21.Zhao Z, Niu Y, Zhao X, et al. EEG microstate in first-episode drug-naive adolescents with depression. J Neural Eng Sep. 2022;15(5). 10.1088/1741-2552/ac88f6. [DOI] [PubMed]
  • 22.Wen Y, Li H, Huang Y, et al. Dynamic network characteristics of adolescents with major depressive disorder: Attention network mediates the association between anhedonia and attentional deficit. Hum brain Mapp Dec. 2023;1(17):5749–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.He XQ, Hu JH, Peng XY, et al. EEG microstate analysis reveals large-scale brain network alterations in depressed adolescents with suicidal ideation. J Affect disorders Feb 1. 2024;346:57–63. [DOI] [PubMed] [Google Scholar]
  • 24.Bao C, Zhang Q, Zou H, et al. EEG microstates as candidate markers of drug-naïve major depressive disorder in young adults with non-suicidal self-injury. J psychiatric Res Nov. 2025;191:238–46. [DOI] [PubMed] [Google Scholar]
  • 25.Hu J, Zhou D, Zhao L, et al. Associations between abnormal electroencephalogram microstates and childhood emotional abuse in adolescent depression. Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences. Nov. 2023;28(11):1678–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rong R, Zhang R, Xu Y, Wang X, Wang H, Wang X. The Role of EEG microstates in predicting oxcarbazepine treatment outcomes in patients with newly-diagnosed focal epilepsy. Seizure Jul. 2024;119:63–70. [DOI] [PubMed] [Google Scholar]
  • 27.Ahn SH, Jang HN, Kim S, Kim MJ, Yum MS, Jeong DH. Identification of topological alterations using microstate dynamics in patients with infantile epileptic spasms syndrome. Sci Rep Mar. 2025;19(1):9490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhang Y, Hui Z, Su Y, et al. EEG microstate analysis in children with prolonged disorders of consciousness. Sci Rep Jul. 2025;18(1):26148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Simkute D, Tarailis P, Griskova-Bulanova I. Signs of Problematic Internet use Affect Resting-State EEG Microstates. Brain topography Sep. 2025;25(6):68. [DOI] [PubMed] [Google Scholar]
  • 30.Rubinov M, Sporns O. Complex network measures of brain connectivity: uses and interpretations. NeuroImage Sep. 2010;52(3):1059–69. [DOI] [PubMed] [Google Scholar]
  • 31.Zhang J, Wang J, Wu Q, et al. Disrupted brain connectivity networks in drug-naive, first-episode major depressive disorder. Biol psychiatry Aug. 2011;15(4):334–42. [DOI] [PubMed] [Google Scholar]
  • 32.Fraschini M, Demuru M, Crobe A, Marrosu F, Stam CJ, Hillebrand A. The effect of epoch length on estimated EEG functional connectivity and brain network organisation. J neural Eng Jun. 2016;13(3):036015. [DOI] [PubMed] [Google Scholar]
  • 33.Lucarini V, Alouit A, Yeh D, et al. Neurophysiological explorations across the spectrum of psychosis, autism, and depression, during wakefulness and sleep: protocol of a prospective case-control transdiagnostic multimodal study (DEMETER). BMC psychiatry Nov. 2023;21(1):860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci methods Mar. 2004;15(1):9–21. [DOI] [PubMed] [Google Scholar]
  • 35.Poulsen AT, Pedroni A, Langer N, Hansen LK. Microstate EEGlab toolbox: an introductory guide. Cold Spring Harbor Laboratory; 2018.
  • 36.Michel CM, Koenig T. EEG microstates as a tool for studying the temporal dynamics of whole-brain neuronal networks: A review. NeuroImage Oct. 2018;15(Pt B):577–93. [DOI] [PubMed] [Google Scholar]
  • 37.Pascual-Marqui RD, Michel CM, Lehmann D. Segmentation of brain electrical activity into microstates: model estimation and validation. IEEE Trans bio-medical Eng Jul. 1995;42(7):658–65. [DOI] [PubMed] [Google Scholar]
  • 38.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol). 2018;57(1):289–300. [Google Scholar]
  • 39.De Pieri M, Rochas V, Apostolopoulou D, et al. EEG microstates, acute phase negative symptoms of schizophrenia and antipsychotic treatment response. Progress in neuro-psychopharmacology & biological psychiatry. Aug. 2025;30:141:111466. [DOI] [PubMed] [Google Scholar]
  • 40.Xue R, Li X, Deng W, et al. Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression. Psychol Med Aug. 2024;54(11):3036–43. [DOI] [PubMed] [Google Scholar]
  • 41.Iftimovici A, Marchi A, Férat V, et al. Electroencephalography microstates imbalance across the spectrum of early psychosis, autism, and mood disorders. Eur psychiatry: J Association Eur Psychiatrists May. 2023;29(1):e41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Oudega ML, van der Werf YD, Dols A, et al. Exploring resting state connectivity in patients with psychotic depression. PLoS ONE. 2019;14(1):e0209908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Thirioux B, Langbour N, Bokam P, et al. EEG microstate co-specificity in schizophrenia and obsessive-compulsive disorder. European archives of psychiatry and clinical neuroscience. Feb. 2024;274(1):207–25. [DOI] [PubMed] [Google Scholar]
  • 44.Zhang Y, Yang T, Cui X, et al. EEG microstates as indicators and predictors of response through 4 weeks of treatment in adolescents with major depressive disorder. J Affect disorders Dec. 2025;15:391:119511. [DOI] [PubMed] [Google Scholar]
  • 45.Bingham KS, Dawson DR, Mulsant BH, Banerjee S, Flint AJ. Relationships Among History of Psychosis, Cognition and Functioning in Later-Life Remitted Major Depression. Am J geriatric psychiatry: official J Am Association Geriatric Psychiatry Feb. 2021;29(2):144–55. [DOI] [PubMed] [Google Scholar]
  • 46.Aydın S, Akın B. Machine learning classification of maladaptive rumination and cognitive distraction in terms of frequency specific complexity. Biomed Signal Process Control. 2022/08/01/;77:103740.
  • 47.Aydın S. Investigation of global brain dynamics depending on emotion regulation strategies indicated by graph theoretical brain network measures at system level. Cogn Neurodyn. 2023;17(2):331–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Aydın S. Cross-validated Adaboost Classification of Emotion Regulation Strategies Identified by Spectral Coherence in Resting-State. Neuroinformatics. 2022;20(3):627–39. [DOI] [PubMed] [Google Scholar]
  • 49.Raeisi Z, Bashiri O, EskandariNasab M, Arshadi M, Golkarieh A, Najafzadeh H. EEG microstate candidate markers for schizophrenia: a novel approach using deep neural networks. Cogn Neurodyn Dec. 2025;19(1):68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Murphy M, Jiang C, Wang LA, et al. Electroencephalographic Microstates During Sleep and Wake in Schizophrenia. Biological psychiatry global open science. Nov. 2024;4(6):100371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sun S, Li X, Zhu J, et al. Graph Theory Analysis of Functional Connectivity in Major Depression Disorder With High-Density Resting State EEG Data. IEEE Trans Neural Syst Rehabil Eng. 2019;27(3):429–39. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (19.2KB, docx)
Supplementary Material 2 (31.9KB, docx)
Supplementary Material 4 (31.7KB, docx)

Data Availability Statement

The datasets generated and analyzed during the current study are not publicly available due to patient confidentiality and ethical restrictions but are available from the corresponding author on reasonable request, subject to approval by the institutional ethics committee of Zigong Mental Health Center.


Articles from BMC Psychiatry are provided here courtesy of BMC

RESOURCES